Kyowa Hakko Kirin sales and marketing update

Kyowa launched Apokyn apomorphine in Japan to treat Parkinson's disease (PD). Apokyn has Orphan Drug status in Japan. Kyowa has rights to the apomorphine hydrochloride injection in Japan and part of ...